- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02517346
Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obstructive Sleep Apnea (OSA) is defined by the presence of repetitive episodes of upper airways collapse during sleep, leading to nocturnal hypoxemia, sleep fragmentation and daytime sleepiness. When untreated, OSA is a risk factor for arterial hypertension , cardiovascular and cerebrovascular diseases, road accidents and a worse quality of life. The application of a continuous positive airways pressure (CPAP) represents the first line therapy in patients with moderate to severe OSA. CPAP treatment improves daytime sleepiness and oxygen saturation , reduces cardiovascular risk, ameliorates neurobehavioral performance, improves quality of life and reduces road accidents. Despite its demonstrated efficacy, CPAP effectiveness is significantly limited by poor adherence. A closer follow up could improve CPAP adherence but it would take up more work and additional costs for sleep units.
So on that account, the investigators propose a study to demonstrate that automatic home treatment monitoring of patients with OSA is a cost-effectiveness alternative approach to patient's management. Moreover, the investigators believe that telemonitoring could improve CPAP compliance and patient's satisfaction and reduce follow-up costs.
Methods:
Prospective and randomized study during three months. Patients diagnosed as OSA in St. Maria's Hospital (Sleep Unit) and requiring CPAP treatment, will be randomized into two groups differing in CPAP compliance monitoring and management .
Group 1 Standard care Patients will be fitted with a mask and given a CPAP and instructed on how to use the device. Patients will follow the standard treatment management. All patients will be visited at 1 month at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. Information will be downloaded from their machines (CPAP adherence, applied CPAP pressure, mask leak, and residual respiratory events…).
Group 2 Telemonitoring Patients will be fitted with a mask and given a CPAP. Each CPAP device will be provided with a modem sending daily compliance information (CPAP adherence, CPAP pressure, mask leak, and residual respiratory events) to a web database.
Patients of both 2 groups will be finally visited at 3 months at sleep unit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lleida, Spain, 25198
- Hospital Arnau de Vilanova-Santa Maria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and Women over 18 years old
- Diagnosed as OSA and requiring CPAP treatment
- Written informed consent form signed.
Exclusion Criteria:
- Patients with impaired lung function (overlap syndrome, obesity hypoventilation syndrome, and restrictive disorders)
- Severe heart failure
- Severe chronic pathology associated
- Psychiatric disorder
- Periodic leg movements
- Pregnancy
- Other dyssomnias or parasomnias
- Patients already treated with CPAP
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard follow up-Sleep Unit
Patients diagnosed as OSA, treated with CPAP and followed up in sleep unit
|
Standard management according to Spanish Respiratory Society guidelines in Sleep Unit.
|
|
Experimental: Telemonitoring
Patients diagnosed as OSA and treated with CPAP in sleep unit, followed up by telemonitoring system
|
Follow up by telemonitoring system during 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CPAP adherence at 3 months
Time Frame: 3 months
|
Number of hours of use per day of CPAP according to the internal clock of the CPAP device
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' satisfaction at 3 months
Time Frame: 3 months
|
Patients will be asked to grade their satisfaction with the follow up care provided by telemonitoring /sleep unit using a questionnaire and a visual analogue scale.
|
3 months
|
|
Cost effectiveness at 3 months
Time Frame: 3 months
|
Costs in each group (CPAP carrying charge, number of visits and calls, number of hospital admissions) will be compared.
|
3 months
|
|
Change from baseline in quality of life at 3 months
Time Frame: 3 months
|
EuroQOL health questionnaire and visual analogue scale will be used.
|
3 months
|
|
Fast detection of the non-adherent patient with telemonitoring
Time Frame: 3 months
|
We assume that telemonitoring could quickly detect non- adherent patients.
|
3 months
|
|
Change in blood pressure at 3 months
Time Frame: 3 months
|
3 months
|
|
|
Change in body mass index at 3 months
Time Frame: 3 months
|
3 months
|
|
|
Abandons at 3 months
Time Frame: 3 months
|
Number of patients lost at follow up at 3 months of CPAP therapy.
|
3 months
|
|
Adverse events at 3 months
Time Frame: 3 months
|
3 months
|
|
|
Change from baseline in snoring at 3 months
Time Frame: 3 months
|
Patients will be asked about the persistence of snoring
|
3 months
|
|
Change from baseline in witnessed apneas at 3 months
Time Frame: 3 months
|
Patients will be asked about the persistence of witnessed apneas
|
3 months
|
|
Change from baseline in nocturia at 3 months
Time Frame: 3 months
|
Patients will be asked about the presence of nocturia.
|
3 months
|
|
Change from baseline in daytime sleepiness at 3 months
Time Frame: 3 months
|
Epworth sleepiness scale will be used.
|
3 months
|
|
Changes in nocturnal gasping at 3 months
Time Frame: 3 months
|
Patients will be asked about the persistence of nocturnal gasping
|
3 months
|
|
Changes in sleep fragmentation at 3 months
Time Frame: 3 months
|
Patients will be asked about the persistence of sleep fragmentation/maintenance insomnia
|
3 months
|
|
Presence of symptoms of restlees leg syndrome at 3 months
Time Frame: 3 months
|
Patients will be asked about the presence of symptoms of restless leg syndrome
|
3 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SEPAR2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea Syndrome
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
University Hospital, AntwerpEnrolling by invitationSleep Apnea | Sleep Apnea Syndrome | Sleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS)Belgium
-
University Medicine GreifswaldEnrolling by invitation
-
Centre Hospitalier de ValenceCompletedObstructive Sleep Apnea/Hypopnea SyndromeFrance
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of Amsterdam; Amsterdam Medical Center (AMC)RecruitingSleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS)Netherlands
-
University Hospital, MontpellierCompletedComplex Sleep Apnea Syndrome | Chronic Heart Failure and | Obstructive Sleep Apnea Syndrome and | Idiopathic Central Sleep Apnea Syndrome | Idiopathic Induced Periodic Breathing | Central Sleep Apnea SyndromeFrance
-
CHU de ReimsRecruitingObstructive Sleep Apnea SyndromeFrance
-
University Hospital, MontpellierCompletedObstructive Sleep Apnea SyndromeFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
Clinical Trials on Standard follow-up
-
Sport Injury Prevention Research CentreGeneral Electric; National Basketball AssociationCompletedTendinopathy | Sports Injuries in Children | Injury, Knee | Injury, AnkleCanada
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Trialbureau... and other collaboratorsRecruitingAdolescent Idiopathic ScoliosisNetherlands
-
University Hospital, Basel, SwitzerlandRecruitingThoracic Surgery | Post Operative Recovery | Mobile Health | Follow-upSwitzerland
-
Institut Claudius RegaudCompleted
-
Massachusetts General HospitalBrigham and Women's HospitalNot yet recruitingHIV Pre-exposure Prophylaxis UseUnited States
-
Azienda Unita Sanitaria Locale di PiacenzaRecruitingHeart Failure With Reduced Ejection Fraction (HFrEF)Italy
-
University of Missouri-ColumbiaEnrolling by invitationDistal Radius Fracture | Distal Radius Fracture FixationUnited States
-
bioAffinity Technologies Inc.RecruitingLung Cancer (Diagnosis)United States
-
Hospital de GranollersRecruitingInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF) | Fibrotic Interstitial Lung Disease | Progressive Pulmonary Fibrosis | Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)Spain
-
Federico II UniversityCompletedHodgkin Lymphoma | Relapse | High Risk